<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01607060</url>
  </required_header>
  <id_info>
    <org_study_id>Lactulona</org_study_id>
    <nct_id>NCT01607060</nct_id>
  </id_info>
  <brief_title>Impact of Laxative Therapy With Lactulose in the Evolution of Organ Dysfunction in Critically Ill Patients.</brief_title>
  <official_title>Impact of Laxative Therapy With Lactulose in the Evolution of Organ Dysfunction in Critically Ill Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      MAIN FEATURES OF THE STUDY: therapeutic intervention. Constipation is a frequent complication&#xD;
      in critical ill patients. The disaccharide lactulose has a laxative osmotic activity. Given&#xD;
      the scant evidence and the potential risk associated with constipation in seriously ill&#xD;
      patients, this study aims to assess the impact of laxative therapy in the prognosis of&#xD;
      critically ill patients.&#xD;
&#xD;
      Study hypothesis: Constipation is part of the clinical spectrum of intestinal dysfunction and&#xD;
      if treated can result in improved prognosis for critically ill patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES: Evaluate the impact of daily laxative therapy in the prognosis of critically ill&#xD;
      patients through the evaluation of organ failure by the sequential organ failure score&#xD;
      assessment (SOFA). Will also be evaluated morbidity data, namely incidence of bloodstream&#xD;
      infection, pneumonia and severe sepsis, days free of mechanical ventilation, length of&#xD;
      hospital stay, ICU and hospital mortality.&#xD;
&#xD;
      The study will be conducted in two intensive care units of Hospital Sao Paulo, UNIFESP.&#xD;
      Inclusion criteria: patients who are mechanically ventilated, with prediction to stay in the&#xD;
      ICU for more than three days and getting at least 20% of full nutritional support in the form&#xD;
      of enteral nutrition. Patients will be randomized into two groups: Group 1 - patients treated&#xD;
      according to medical prescription. Group 2 - patients will receive lactulone in order to&#xD;
      evacuate daily. The patient included in the intervention group will receive latulose 30 ml of&#xD;
      8 in 8 hours. Patients will be monitored, adjusted doses and procedures, if necessary. It is&#xD;
      intended to include 44 patients per group.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in SOFA score</measure>
    <time_frame>At the moment of inclusion and 14 days latter</time_frame>
    <description>Will evaluate the change in SOFA score between the time of enrollment and 14 days after enrollment, or discharge, or death if it occurs before that date.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">88</enrollment>
  <condition>Constipation</condition>
  <arm_group>
    <arm_group_label>Lactulone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receiving lactulone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Observational group. Compare to lactulone group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactulone</intervention_name>
    <description>Patients will receive lactulone to daily laxation</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Lactulone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ICU patients expected to stay for 3 more days, on mechanical ventilation and receiving&#xD;
             at least 20% of calculated nutrient intake enterally.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  younger than 18 years,&#xD;
&#xD;
          -  pregnancy,&#xD;
&#xD;
          -  contraindication to enteral nutrition,&#xD;
&#xD;
          -  patients with liver disease,&#xD;
&#xD;
          -  contraindications to the use of lactulose,&#xD;
&#xD;
          -  patients with poor prognosis or without full therapeutic indication investment,&#xD;
&#xD;
          -  presence of colostomy or ileostomy,&#xD;
&#xD;
          -  intestinal diseases,&#xD;
&#xD;
          -  such as disease Crohn's,&#xD;
&#xD;
          -  ulcerative colitis,&#xD;
&#xD;
          -  short bowel syndrome.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>São Paulo Hospital</name>
      <address>
        <city>São Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <study_first_submitted>May 24, 2012</study_first_submitted>
  <study_first_submitted_qc>May 25, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2012</study_first_posted>
  <last_update_submitted>January 5, 2015</last_update_submitted>
  <last_update_submitted_qc>January 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>Rodrigo Palácio de Azevedo</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Critically ill patients</keyword>
  <keyword>intestinal failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

